Page 112 - Chief Editor News Today

Tread Carefully Into Virtual Clinical Trials By Ed Miseta, Chief Editor, Clinical Leader Follow Me On Twitter @EdClinical With the COVID-19 pandemic’s impact on clinical trials in the U.S. and around the world, everyone is suddenly focused on virtual (decentralized) clinical trials. But if you plan to move your trials to a virtual model, at least one industry executive is recommending that you use caution when doing so. “Everyone wants to migrate to virtual trials, but when doing so I think...

A Behind The Scenes Peek Into Oyster Point Pharmas CEO, Jeffrey Nau Source: Life Science Leader Follow Me On Twitter @RfwrightLSL Jeffrey Nau, Ph.D., president and CEO, Oyster Point Pharma. When I sat down to interview Jeffrey Nau, Ph.D., president and CEO of Oyster Point Pharma, I asked him how he became fascinated with the human eye. “Did your parents work in the medical field?” I asked. “No,” he replied. Nau then informed me that neither of his parents had graduated from college, and...

BW Businessworld Security Leadership Summit 2020 Deliberates The Security Of The Nation’s Enterprises 15th edition of the annual Security Leadership Summit 2020 was organised by CAPSI and APDI. Summit deliberated the role of private security firms during pandemic as they led the way in ensuring a completely safe and secure environment and even now during the transition to a post-Covid19 era. While appreciating the government for the support during pandemic, security leaders also hoped that th...

X4 Pharma Adjusts Clinical Trials For A COVID World By Ed Miseta, Chief Editor, Clinical Leader Follow Me On Twitter @EdClinical X4 Pharma is a company focused on delivering innovative treatments for patients with rare diseases of the immune system. With the COVID pandemic afflicting patients around the world, those with a compromised immune system were at even greater risk. The company is currently conducting a global Phase 3 trial that was underway when the pandemic hit. The trial is for pati...

7 Biopharma CEOs On Who And What To Pay Attention To In 2021 And Beyond Source: Life Science Leader Follow Me On Twitter @RfwrightLSL When you make the decision to involve 15 biopharmaceutical industry CEOs in an article for the annual outlook issue, you risk having way more content than can possibly be wedged into the printed article. Thank goodness Life Science Leader developed the online-exclusive Beyond The Printed Page section of the magazine. For this installment, we have six biopharmace...

Latest from our journals Authors | Researchers Share Post You’ve decided which journal you want to submit your research to – now what? Catherine Farrell, Editorial Production Editor at Hindawi, takes us through the process from submission to publication. Submitting to a publisher for the first time can be daunting if you’re not familiar with how they work. At Hindawi, all our journals follow a standardized, straightforward process from submission to publication, with help given to autho...

Written By: mickysavage - Date published: 7:55 am, December 17th, 2020 - 66 comments These are in remarkably good shape.  Who would have predicted that dealing properly with a global pandemic would have had better results for the economy than timidly dealing with it and trying to ensure that economic activity continued? And that making baby boomers stay home and spend their wealth on new kitchens or meals out or local holida...

It has never ceased to surprise me that those who profit at the expense of others are so unaware of the harm suffered by those they exploit, and are so convinced that they have a right to do the exploiting and that their profit is a proper and justifiable reward ... 3 days ago The government’s recent housing package may work; will it do enough? Trick Question: Does New Zealand have a capital gains tax on housing? If you ask the Prime Minister she will say not. It is true that her government ...

Bidens selection of Jennifer Granholm as Secretary of Energy is a good choice. A hard worker, a great communicator, and a champion of renewable energy. The BAU everyone is adamant is about to occur – will not. Sure, change is not going to be fast enough for most round these parts, but this lady is no dinosaur nor a rich crony. Hard working experienced people. I reckon Joes doing alright building a team considering everyones expectations are so low. Andre 2.1 More signi...

Not a good day at the office for Mallard today. $333k cost to the tax payer so far, plus a further $37k in legal fees and the accused apparently has a case against parliamentary services. I think this is going to cost the tax payer a lot more half a million. This really irks me when my taxes go towards defending MPs for saying stupid things. The funds could have fed a few families at Christmas. ianmac 1.1 Jester: the accused apparently has a case against parliamentary serv...